...Beijing antibody play Mabworks raises $160M Mabworks Biotech Co. Ltd. raised RMB1.1 billion ($160 million) in series C1 and...
...Targets eIF4E - Eukaryotic translation initiation factor 4E Elizabeth S. Eaton and Hongjiang Li, Staff Writers Wellington Partners Mabworks Biotech Co. Ltd. Lantern...

...Details regarding the start-ups’ pipelines and financing histories are not disclosed. Last year, Jacobio and Mabworks Biotech Co. Ltd....

...begin a Phase I trial this year of innovative candidate MIL62 to treat non-Hodgkin's lymphoma. Becky Simon Mabworks Biotech Co. Ltd....

...of Manitoba, the Public Health Agency of Canada, the Institute of Basic Medical Sciences and Mabworks Biotech Co. Ltd....
...Inc., Toronto, Ontario Humabs BioMed S.A., Bellinzona, Switzerland Institute of Basic Medical Sciences, Beijing, China Mabworks Biotech Co. Ltd....
...Medicine , Mapp Bio and the Public Health Agency of Canada (PHAC) teamed up with Mabworks Biotech Co. Ltd....

...and Renfeng Guo University collaborators: Friedrich Schiller University and University of Michigan Corporate partners: Beijing Mabworks Biotech Co. Ltd....